Robert Peter Kadlec Mi Nk Therapeutics, Inc. (INKT) insider trading activity

INKT Quotes by TradingView

Robert Peter Kadlec is of MiNK Therapeutics, Inc.. Currently has a direct ownership of 19,126 shares of INKT, which is worth approximately $244,430. The most recent transaction as insider was on Dec 01, 2025, when has been sold 1,218 shares (Common Stock) at a price of $11.09 per share, resulting in proceeds of $13,507. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.1K
6.8% 3M change
55.67% 12M change
Total Value Held $244,430

Robert Peter Kadlec Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2025
BUY
Grant, award, or other acquisition
$13,507 $11.09 p/Share
1,218 Added 5.99%
19,126 Common Stock
Sep 02 2025
BUY
Grant, award, or other acquisition
$13,513 $13.86 p/Share
975 Added 5.16%
17,908 Common Stock
Jun 02 2025
BUY
Grant, award, or other acquisition
$13,501 $7.17 p/Share
1,883 Added 28.84%
4,647 Common Stock
Mar 03 2025
BUY
Grant, award, or other acquisition
$13,501 $8.79 p/Share
1,536 Added 35.72%
2,764 Common Stock
Dec 01 2024
BUY
Grant, award, or other acquisition
$8,968 $0.73 p/Share
12,286 Added 50.0%
12,286 Common Stock
RPK

Robert Peter Kadlec

New York, NY

Track Institutional and Insider Activities on INKT

Follow MiNK Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INKT shares.

Notify only if

Insider Trading

Get notified when an Mi Nk Therapeutics, Inc. insider buys or sells INKT shares.

Notify only if

News

Receive news related to MiNK Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INKT